Dec 2022 $25 M No. 5 $10 to $50 million 1
Ribon Therapeutics, Inc.: Raise no. 5, Dec 2022 × Investors in this round 1 investor had bought by the notice of Dec 22, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gary Sutton · Executive Officer Paul Brannelly · Executive Officer Prakash Raman · Executive Officer, Director Cameron Wheeler · Director Emma Reeve · Director Eyal Lifschitz · Director James Audia · Director Jeff Goater · Director Jodie Morrison · Director Jonathan Root · Director Laura Brass · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Prakash Raman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 22, 2022. Read the notice at the SEC .
equity SEC Jun 2021 $25 M No. 4 $10 to $50 million 16
Ribon Therapeutics, Inc.: Raise no. 4, Jun 2021 × Investors in this round 16 investors had bought by the notice of Jun 14, 2021: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $60 M offered; $35 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Edward M. Stewart · Executive Officer Victoria M. Richon · Executive Officer, Director Cameron M. Wheeler · Director Emma M. Reeve · Director James M. Audia · Director Jodie M. Morrison · Director Jonathan M. Root · Director Laura M. Brass · Director Marian M. Nakada · Director Svennilson Peter · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Victoria M. Richon, Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 14, 2021. Read the notice at the SEC .
equity SEC Dec 2018 $25 M No. 3 $10 to $50 million 10
Ribon Therapeutics, Inc.: Raise no. 3, Dec 2018 × Investors in this round 10 investors had bought by the notice of Jan 4, 2019: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $65 M offered; $40 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David M. Cordo · Executive Officer Victoria M. Richon · Executive Officer, Director Anja M. Koenig · Director Cameron M. Wheeler · Director James M. Audia · Director Jonathan M. Root · Director Marian M. Nakada · Director Svennilson Peter · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Victoria M. Richon, Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 4, 2019. Read the notice at the SEC .
equity SEC Oct 2017 $20 M No. 2 $10 to $50 million 8
Ribon Therapeutics, Inc.: Raise no. 2, Oct 2017 × Investors in this round 8 investors had bought by the notice of Oct 10, 2017: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David M. Cordo · Executive Officer Victoria M. Richon · Executive Officer, Director Cameron M. Wheeler · Director Jonathan M. Root · Director Laurence Lasky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Victoria M. Richon, Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 10, 2017. Read the notice at the SEC .
equity SEC Nov 2015 $24 M No. 1 $10 to $50 million 5
Ribon Therapeutics, Inc.: Raise no. 1, Nov 2015 × Investors in this round 5 investors had bought by the notice of Nov 23, 2016: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $24 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Victoria M. Richon · Executive Officer, Director Cameron M. Wheeler · Director Jonathan M. Root · Director Laurence Lasky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Victoria M. Richon, President. Source: SEC Form D and 1 amendment, newest notice filed Nov 23, 2016. Read the notice at the SEC .
equity SEC